Antimalarial activities of polyhydroxyphenyl and hydroxamic acid derivatives

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 9, 1998, Pages 2456-2458

  Holland, Kevin P ^a   Elford, Howard L ^b   Bracchi, Valerie ^c   Annis, Charles G ^a   Schuster, Sheldon M ^a   Chakrabarti, Debopam ^a,c  

^a UNIVERSITY OF FLORIDA   (United States)

^b Molecules for Health Inc   (United States)

^c UNIVERSITY OF CENTRAL FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; HYDROXAMIC ACID DERIVATIVE; RIBONUCLEOTIDE REDUCTASE; UNCLASSIFIED DRUG; VF 147; VF 149;

ANTIPROTOZOAL ACTIVITY; ARTICLE; DRUG POTENCY; DRUG SCREENING; MALARIA; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

EID: 0031680657     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.9.2456     Document Type: Article

References (19)

1. Carmichael, J., B. M. J. Cantwell, K. A. Mannix, D. Veale, H. L. Elford, R. Blackie, D. J. Kerr, S. B. Kaye, and A. L. Harris. 1990. A phase I pharmacokinetic study of didox administered by 36 hr infusion. Br. J. Cancer 61:447-450.
2. Chakrabarti, D., S. M. Schuster, and R. Chakrabarti. 1993. Cloning and characterization of subunit genes of ribonucleotide reductase, a cell-cycle-regulated enzyme, from Plasmodium falciparum. Proc. Natl. Acad. Sci. USA 90:12020-12024.
3. Desjardins, R. E., C. J. Canfield, J. D. Haynes, and J. D. Chulay. 1979. Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob. Agents Chemother. 16:710-718.
4. Elford, H. L., R. M. Elford, G. L. Wampler, and B. van't Riet. 1982. New cancer chemotherapeutic agents that inhibit ribonucleotide reductase. In T. Bardos and T. Kalman (ed.), New approaches to the design of antineoplastic agents. Elsevier Science, New York, N.Y.
5. Elford, H. L., M. Freese, E. Passamani, and H. P. Morris. 1970. Ribonucleotide reductase and cell proliferation. I. Variations of ribonucleotide reductase activity with tumor growth rate in a series of rat hepatomas. J. Biol. Chem. 245:5228-5233.
6. Elford, H. L., and B. van't Riet. 1989. The inhibition of nucleoside diphosphate reductase by hydroxybenzohydroxamic acid derivatives. In J. G. Cory and A. H. Cory (ed.), Inhibitors of ribonucleoside diphosphate reductase activity. Pergamon Press, Oxford, United Kingdom.
7. Elford, H. L., B. van't Riet, G. L. Wampler, A. L. Lin, and R. M. Elford. 1981. Regulation of ribonucleotide reductase in mammalian cells by chemotherapeutic agents. Adv. Enzyme Regul. 19:151-168.
8. Elford, H. L., G. L. Wampler, and B. van't Riet. 1979. New ribonucleotide reductase inhibitors with antineoplastic activity. Cancer Res. 39:844-851.
9. Klayman, D. L., N. Acton, and J. P. Scovill. 1986. 2-Acetylpyridine thiosemicarbazones. 12. Derivatives of 3-acetylisoquinoline as potential antimalarial agents. Arzneim-Forsch. 36:10-13.
10. Klayman, D. L., C. J. Mason, and J. P. Scovill. 1984. 2-Acetylpyridine thiosemicarbazones. 10. 2-Propionyl-, 2-butryl-. and 2-(2-methylpropionyl) pyridine thiosemicarbazones as potential antimalarial agents. Arzneim-Forsch. 34:1701-1703.
11. McCullagh, P., and J. A. Neider. 1989. Generalized linear models, 2nd ed. Chapman and Hall, London, United Kingdom.
12. Moore, E. C., and A. C. Sartorelli. 1989. The inhibition of ribonucleotide reductase by a-(N)-heterocyclic carboxaldehyde thiosemicarbazones. In J. G. Cory and A. H. Cory (ed.), Inhibitors of ribonucleoside diphosphate reductase activity. Pergamon Press, Oxford, United Kingdom.
13. Pace, B. S., H. L. Elford, and G. Stamatoyannopoulos. 1994. Transgenic mouse model of pharmacologic induction of fetal hemoglobin: studies using a new ribonucleotide reductase inhibitor, Didox. Am. J. Hematol. 45:136-141.
14. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
15. Stubbe, J. 1990. Ribonucleotide reductases. Adv. Enzymol. Relat. Areas Mol. Biol. 63:349-419.
16. Thelander, L., and P. Reichard. 1979. Reduction of ribonucleotides. Annu. Rev. Biochem. 48:133-158.
17. van't Riet, B., G. L. Wampler, and H. L. Elford. 1979. Synthesis of hydroxy- and amino-substituled benzohydroxamic acids: inhibition of ribonucleotide reductase and antitumor activity. J. Med. Chem. 22:589-592.
18. Veale, D., J. Carmichael, B. M. J. Cantwell, H. L. Elford, R. Blackie, D. J. Kerr, S. B. Kaye, and A. L. Harris. 1988. A phase I and pharmacokinetic study of didox: a ribonucleotide reductase inhibitor. Br. J. Cancer. 58:70-72.
19. Weber, G. 1977. Enzymology of cancer cells. N. Engl. J. Med. 296:486-493.